Raffaelle J. Marchigianni, M.D., Sentara Surgery Specialists, discusses his area of focus, approach to patient care, and what's new and upcoming in Thoracic surgery.
So my name is Rachel Market. Johnny. I'm a thoracic surgeon at Centrally Hospital. My main focus is thoracic oncology as well as benign on other malignancies of the thoracic region. My path to medicine started pretty much before I was born. My mom was convinced I was going to be a surgeon. And from the very minute I was born to the time you see me now, it was never I never looked back. She had in her mind that I was gonna be a surgeon. She always pointed in my hands and said, These are gonna be surgeons hands and she even wrote a book about it. And so here I am today, I like to treat them the way I would want myself for my family to be treated. A lot of what I do is oncology, and so it's a demanding field, both mentally and physically, and my patients are going through quite a lot. A lot of its new to them. They're not familiar with what's happening for them. It's a totally different world. They're not in medicine, they don't really understand, and it's my job to treat them. Aziz, carrying a compassionate as I can and looking at them as human beings that if I was going through this or my family, how would they want to be treated? It's not always easy to do you bring your work home with you sometimes, but in general I try to be as most carrying compassionate I can, knowing that we're dealing with a very severe disease. So the reason I came to Sentara has a lot to do where I was trained, I did my fellowship at University of Iowa and my mentor, Dr Anna Tony New Doctor Tan Um, from back in Michigan. It end up working out that he contacted her and I came out for the interview. My family and I love the location. The practice was everything I wanted. It was bread and butter. General Thor ASIC surgery. I was able to teach and train residents as well as medical students. I had partners that cared and had the same mindset I did, and I felt like I was being brought into a practice where I was gonna be supported and kind of helped me to mature as a surgeon. And so it really just worked out that someone new, someone and we love the location. And here we are four years later and we couldn't be happier. So some of the new and hot topics not a lot has changed from a surgery standpoint. Surgery is still the gold standard, and that, you know, will, I think, continue for for a long, long time. We have the best local control and the lowest longtime re occurrence. There are some new things coming out. One of the newspapers that I've looked at and red was, unfortunately, the statistics on never smokers and an increase in lung cancer and those patient population. So something that we're focusing on and how we can direct care for those patients on drily look at different medications to use. And with that said, there's a lot of new medications coming out immunotherapy for both stage one lung cancers as well as some more advanced lung cancers. And that's something more the oncologist would focus on. But, you know, I've been notified that there are one or two new medications coming out that we can hopefully use for early lung cancer that would give them better long term survival, even with surgery. Eso Hopefully with time, we're gonna have a lot of new medications targeting specific receptors on cells and give patients longer disease, free intervals and survival.
Related Presenters
